Bausch + Lomb Corporation
Bausch + Lomb Corporation (BLCO.TO) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
blco.to · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Bausch + Lomb Corporation (BLCO.TO) measures how much investors pay for each dollar of the company's trailing earnings. BLCO.TO's current PE ratio of N/A is calculated by dividing its stock price of $21.10 by its TTM earnings per share of -$0.62.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2018 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 4 fiscal years · Front-end computedMinQ1 · 25%30.9x
MedianQ3 · 75%362.2x
Max
At N/A, BLCO.TO's current P/E is lower than in 0% of its annual fiscal year readings over the past 4 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Instruments & Supplies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Bausch + Lomb CorporationYou BLCO.TO | $7.5B | N/A | — | -$0.62 |
 Bausch Health Companies Inc. BHC.TO | $2.7B | 16.11x | — | $0.43 |
 Curaleaf Holdings, Inc. CURA.TO | $3.6B | N/A | — | -$0.93 |
 Spectral Medical Inc. EDT.TO | $408M | N/A | — | -$0.17 |
 Fennec Pharmaceuticals Inc. FRX.TO | $356M | N/A | — | -$0.36 |
 Ocumetics Technology Corp. OTC.V | $32M | N/A | — | -$0.04 |
 Sona Nanotech Inc. SONA.CN | $30M | N/A | — | -$0.03 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-1.02 | — | |
2024-12-31 FY2024 | — | $-0.90 | — | |
2023-12-31 FY2023 | — | $-0.74 | — | |
2022-12-31 FY2022 | 362.16x | $0.04 | +834.1% | |
2021-12-31 FY2021 | 38.77x | $0.52 | — | |
2020-12-31 FY2020 | — | $-0.05 | — | |
2019-12-31 FY2019 | 23.04x | $0.85 | +150.2% | |
2018-12-31 FY2018 | 9.21x | $2.03 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Bausch + Lomb Corporation (BLCO.TO) measures how much investors pay for each dollar of the company's trailing earnings. BLCO.TO's current PE ratio of N/A is calculated by dividing its stock price of $21.10 by its TTM earnings per share of -$0.62.
Frequently asked questions
BLCO.TO pe ratio · 6 questionsBLCO.TO's current PE ratio is N/A as of 2026-06-08, based on a stock price of $21.10 and TTM EPS of -$0.62. Data sourced from Financial Modeling Prep via BLCO.TO's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Bausch + Lomb Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08